DRREDDY.NS Dr. Reddy's Laboratories Ltd.
Price history
Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.
Technical indicators
ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.
MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.
Delivery volume
| Date | Traded Qty | Delivery Qty | Delivery % |
|---|---|---|---|
| 2026-08-28 | 682712 | 310093 | 45.42% |
| 2026-08-27 | 1044405 | 560436 | 53.66% |
| 2026-08-26 | 1993156 | 1159893 | 58.19% |
| 2026-08-25 | 1569853 | 840229 | 53.52% |
| 2026-08-24 | 2248634 | 1387680 | 61.71% |
| 2026-08-21 | 1246756 | 705585 | 56.59% |
| 2026-08-20 | 1031107 | 611286 | 59.28% |
| 2026-08-19 | 1150424 | 610641 | 53.08% |
| 2026-08-18 | 805633 | 466296 | 57.88% |
| 2026-08-17 | 2183094 | 1244464 | 57.00% |
| 2026-08-14 | 2136998 | 1402687 | 65.64% |
| 2026-08-13 | 1799813 | 961939 | 53.45% |
| 2026-08-12 | 2366909 | 1497165 | 63.25% |
| 2026-08-11 | 3936813 | 2189612 | 55.62% |
| 2026-08-10 | 1770609 | 1196457 | 67.57% |
| 2026-08-07 | 1072438 | 701262 | 65.39% |
| 2026-08-06 | 1329196 | 803721 | 60.47% |
| 2026-08-05 | 1883679 | 1146705 | 60.88% |
| 2026-08-04 | 2165315 | 1217599 | 56.23% |
| 2026-08-03 | 2150927 | 1110142 | 51.61% |
Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers DRREDDY.NS to fetch more history.
Insider trading activity
| Disclosed | Person | Category | Type | Mode | Quantity | Value (₹) | Resulting stake | |
|---|---|---|---|---|---|---|---|---|
| 30 Mar 2026 | Patrick Aghanian | - | Buy | ESOP | 3675 | 4784482 | 0.00% | XBRL |
| 12 Dec 2025 | Tricia Wetzel | - | Buy | ESOP | 4275 | 5417067 | 0.00% | XBRL |
| 17 Sep 2025 | Patrick Aghanian | - | Buy | ESOP | 4775 | 6285810 | 0.00% | XBRL |
| 02 Sep 2025 | Anjum Swaroop | - | Buy | ESOP | 10495 | 13232096 | 0.00% | XBRL |
| 04 Aug 2025 | C Swamynathan | - | Sell | ESOP | 7450 | 9622420 | 0.00% | XBRL |
| 04 Aug 2025 | C Swaminathan | - | Sell | Market Sale | 7450 | 9626145 | 0.00% | XBRL |
| 24 Jun 2025 | Jeff Jorgenson | - | Buy | ESOP | 1495 | 1981548 | 0.00% | XBRL |
| 24 Jun 2025 | Milan Kalawadia | - | Buy | ESOP | 8440 | 11186798 | 0.00% | XBRL |
| 18 Jun 2025 | Anjum Swaroop | - | Buy | ESOP | 2050 | 2790980 | 0.00% | XBRL |
| 18 Jun 2025 | Tricia Wetzel | - | Buy | ESOP | 1670 | 2273622 | 0.00% | XBRL |
| 18 Jun 2025 | Lalitha Subramanian | - | Buy | ESOP | 1250 | 1701813 | 0.00% | XBRL |
| 26 Sep 2024 | C Swaminathan | - | Sell | Others | 1700 | 11307403 | 0.00% | XBRL |
| 26 Sep 2024 | Vincent Colicchio | - | Buy | ESOP | 1594 | 10445482 | 0.00% | XBRL |
| 26 Sep 2024 | Anjum Swaroop | - | Buy | ESOP | 1412 | 9252836 | 0.00% | XBRL |
| 04 Sep 2024 | Tricia Wetzel | - | Buy | ESOP | 594 | 4040850 | 0.00% | XBRL |
| 04 Sep 2024 | Jeff Jorgenson | - | Buy | ESOP | 474 | 3277236 | 0.00% | XBRL |
| 04 Sep 2024 | Bryan Dixon | - | Buy | ESOP | 150 | 1037100 | 0.00% | XBRL |
| 04 Sep 2024 | Milan Kalawadia | - | Buy | ESOP | 814 | 5627996 | 0.00% | XBRL |
| 04 Sep 2024 | Sanjay Choubey | - | Buy | ESOP | 215 | 1486510 | 0.00% | XBRL |
| 04 Sep 2024 | Juan Carlos Alvarez | - | Buy | ESOP | 145 | 1002530 | 0.00% | XBRL |
SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers DRREDDY.NS to fetch more.
Extract this company (financials + ratios + citations): CSV · XLSX
Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score
Ratios
This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.
Growth & earnings trend
Revenue & Profit CAGR
Operating Margin Trend
ROCE Trajectory
Earnings Quality
Net profit or operating cash flow was zero or negative in the base or latest year — a growth-rate comparison isn't defined across a sign change.
Sector-Relative Percentile (Healthcare)
Quarterly trend
| Metric (to shareholders basis) | Q4 FY2023-24 | Q1 FY2024-25 | Q2 FY2024-25 | Q3 FY2024-25 | Q4 FY2024-25 | Q1 FY2025-26 | Q2 FY2025-26 | Q3 FY2025-26 | Q4 FY2025-26 | Q1 FY2026-27 | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹7,113.80 Cr. | ₹7,696.10 Cr. | ₹8,038.20 Cr. | ₹8,381.20 Cr. | ₹8,528.40 Cr. | ₹8,572.10 Cr. | ₹8,828.30 Cr. | ₹8,753.40 Cr. | ₹7,546.40 Cr. | ₹8,099.80 Cr. | RevenueFromOperations |
| Net Profit | ₹1,309.80 Cr. | ₹1,392.40 Cr. | ₹1,255.70 Cr. incl. minority ₹1,341.90 Cr. | ₹1,413.70 Cr. incl. minority ₹1,404.20 Cr. | ₹1,593.30 Cr. incl. minority ₹1,586.70 Cr. | ₹1,418.10 Cr. incl. minority ₹1,409.90 Cr. | ₹1,347.10 Cr. incl. minority ₹1,336.80 Cr. | ₹1,209.90 Cr. incl. minority ₹1,189.60 Cr. | ₹220.90 Cr. incl. minority ₹221.30 Cr. | ₹444.30 Cr. incl. minority ₹435.60 Cr. | ProfitLossForPeriod |
Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers DRREDDY.NS to fetch more.
Source document — income statement (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| ProfitOrLossAttributableToOwnersOfParent | 41960000000.0 |
| PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital | 835000000.0 |
Source document — balance sheet (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| CurrentAssets | 301793000000.0 |
| CurrentLiabilities | 167474000000.0 |
| EquityAttributableToOwnersOfParent | 378915000000.0 |
| BorrowingsCurrent + BorrowingsNoncurrent | 62935000000.0 |